Anticoagulation Not Routinely Needed After TAVR: ADAPT-TAVR ...Middle East

Medscape - News
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual antiplatelet therapy, but no reduction in cerebral events or neurocognitive function Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Anticoagulation Not Routinely Needed After TAVR: ADAPT-TAVR )

Apple Storegoogle play

Also on site :